Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 2, 2006, Pages 547-555

  Kotani, Tohru ^a   Kobata, Atsushi ^a   Nakamura, Eiji ^a   Amagase, Kikuko ^a   Takeuchi, Koji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 2; ILOPROST; INDOMETACIN; PROSTACYCLIN RECEPTOR; ROFECOXIB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REPERFUSION INJURY; STOMACH LESION; UPREGULATION; WILD TYPE;

ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; GASTRIC MUCOSA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, EPOPROSTENOL; REPERFUSION INJURY; STOMACH ULCER;

EID: 31144475770     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.093195     Document Type: Article

References (45)

1. Araki H, Ukawa H, Sugawa Y, Yagi K, Suzuki K, and Takeuchi K (2000) The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach. Aliment Pharmacol Ther 14 (Suppl 1):116-124.
2. Chamoun F, Burne M, O'Donnell M, and Rabb H (2000) Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury. Front Biosci 5:E103-E109.
3. Cheung JY, Bonventre JV, Malis CD, and Leaf A (1986) Calcium and ischemic injury. N Engl J Med 314:1670-1676.
4. Davies NM, Sharkey KA, Asfaha S, Macnaughton WK, and Wallace JL (1997) Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 11:1101-1108.
5. Dimmitt RA, Glew R, Colby C, Brindle M, Skarsgard E, and Moss RL (2003) Serum cytosolic beta-glucosidase activity in a rat model of necrotizing enterocolitis. Pediatr Res 54:462-465.
6. Farber JL, Chien KR, and Mittnacht S Jr (1981) Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia. Am J Pathol 102:271-281.
7. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, and Otomo S (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/ cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
8. Granger DN and Kubes P (1994) The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55:662-675.
9. Harada N, Okajima K, Liu W, and Uchiba M (2000) Activated neutrophils impair gastric cytoprotection role of neutrophil elastase. Dig Dis Sci 45:1210-1216.
10. 2) prevents stress-induced gastric mucosal injury in rats primarily by inhibiting leukocyte activation. Prostaglandins Other Lipid Mediat 57:291-303.
11. Hiratsuka T, Futagami S, Tatsuguchi A, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Shinoki K, Nishigaki H, Wada K, et al. (2004) Distinct roles of COX-1 and COX-2 in gastric ischemia-reperfusion injuries in mice (Abstract). Gastroenterology 126: A-543.
12. 2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation. J Biol Chem 278:12752-12758.
13. Kitano M, Wada K, Kamisaki Y, Nakamoto K, Kishimoto Y, Kawasaki H, and Itoh T (1997) Effects of cimetidine on acute gastric mucosal injury induced by ischemiareperfusion in rats. Pharmacology 55:154-164.
14. Koga T, Shibahara K, Kabashima A, Sumiyoshi Y, Kimura Y, Takahashi I, Kakeji Y, and Maehara Y (2004) Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer. Hepatogastroenterology 51:1626-1630.
15. Konturek SJ and Robert A (1982) Cytoprotection of canine gastric mucosa by prostacyclin: possible mediation by increased mucosal blood flow. Digestion 25:155-163.
16. Krawisz JE, Sharon P, and Stenson WF (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models. Gastroenterology 87:1344-1350.
17. Kuzumoto Y, Sho M, Ikeda N, Mizuno T, Hamada K, Akashi S, Tsurui Y, Kashizuka H, Nomi T, Kanehiro H, and Nakajima Y (2005) Role of EP4 prostaglandin E2 receptor in the ischemic liver. Transplant Proc 37:422-424.
18. Laudanno OM, Cesolari JA, Esnarriaga J, Rista L, Piombo G, Maglione C, Aramberry L, Sambrano J, Godoy A, and Rocaspana A (2001) Gastrointestinal damage induced by celecoxib and rofecoxib in rats. Dig Dis Sci 46:779-784.
19. Maricic N, Ehrlich K, Gretzer B, Schuligoi R, Respondek M, and Peskar BM (1999) Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach. Br J Pharmacol 128:1659-1666.
20. McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, and Andreasson K (2004) Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24:257-268.
21. Miura S, Tatsuguchi A, Wada K, Takeyama H, Shinji Y, Hiratsuka T, Futagami S, Miyake K, Gudis K, Mizokami Y, et al. (2004) Cyclooxygenase-2- regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol 287:G444-G551.
22. Mizuno H, Akamatsu T, and Kasuga M (1997) Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112:387-397.
23. Muscara MN, Vergnolle N, Lovren F, Triggle CR, Elliott SN, Asfaha S, and Wallace JL (2000) Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br J Pharmacol 129:1423-1430.
24. Nakamoto K, Wada K, Kitano M, Kishimoto Y, Ashida K, Kamisaki Y, Kawasaki H, and Itoh T (1998) The role of endogenous acid in the development of acute gastric ulcer induced by ischemia-reperfusion in the rat. Life Sci 62:PL63-PL69.
25. Narumiya S and FitzGerald GA (2001) Genetic and pharmacological analysis of prostanoid receptor function. J Clin Investig 108:25-30.
26. Piper HM, Meuter K, and Schafer C (2003) Cellular mechanisms of ischemiareperfusion injury. Ann Thorac Surg 75:S644-S668.
27. Riaz AA, Wan MX, Schafer T, Dawson P, Menger MD, Jeppsson B, and Thorlacius H (2002) Allopurinol and superoxide dismutase protect against leucocyteendothelium interactions in a novel model of colonic ischaemia-reperfusion. Br J Surg 89:1572-1580.
28. Saika M, Ueyama T, and Senba E (1999) Prostacyclin analog prevents stress-induced expression of immediate early genes and gastric mucosal lesions in the rat stomach. Life Sci 64:PL235-PL240.
29. Schmedtje JF, Ji YS, Liu WL, DuBois RN, and Runge MS (1997) Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272:601-608.
30. Seidler U, Beinborn M, and Sewing KF (1989) Inhibition of acid formation in rabbit parietal cells by prostaglandins is mediated by the prostaglandin E2 receptor. Gastroenterology 96:314-320.
31. Soll AH, Weinstein WM, Kurata J, and McCarthy D (1991) Nonsteroidal antiinflammatory drugs and peptic ulcer disease. Ann Intern Med 114:307-319.
32. Sugimoto Y, Namba T, Honda A, Hayashi Y, Negishi M, Ichikawa A, and Narumiya S (1992) Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem 267:6463-6466.
33. Suzuki K, Araki H, Mizoguchi H, and Takeuchi K (2001) E type prostaglandin inhibits indomethacin-induced gastric lesions in rats through EP1 receptors: Importance of antigastric motility action. Digestion 63:92-101.
34. Takeeda M, Yamato M, Kato S, and Takeuchi K (2003) Cyclooxygenase isozymes involved in adaptive functional responses in rat stomachs following barrier disruption. J Pharmacol Exp Ther 307:713-719.
35. Takeuchi K, Araki H, Komoike Y, Umeda M, and Suzuki K (2002a) Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice. J Pharmacol Exp Ther 297:1160-1165.
36. 2 and EP receptor subtypes, in Frontiers of Gastrointestinal Research: Gastrointestinal Mucosal Repair and Experimental Therapeutics (Cho CH and Wang JY eds) vol 25, pp 227-242, Karger AG, Basel.
37. Takeuchi K, Ohno T, and Okabe S (1986) Variations of gastric transmucosal potential difference and lesion formation in the rat during hemorrhagic shock. Gastroenterology 91:1113-1122.
38. Tanaka A, Hase S, Miyazawa T, and Takeuchi K (2002) Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal antiinflammatory drug-induced intestinal damage. J Pharmacol Exp Ther 300:754-761.
39. Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, Hizaki H, Tuboi K, Katsuyama M, Ichikawa A, et al. (1998) Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature (Lond) 395:281-284.
40. Vane JR and Botting RM (1995) New insights into the mode of action of antiinflammatory drugs. Inflamm Res 44:1-10.
41. Wada K, Kamisaki Y, Kitano M, Kishimoto Y, Nakamoto K, and Itoh T (1996) A new gastric ulcer model induced by ischemia-reperfusion in the rat: role of leukocytes on ulceration in rat stomach. Life Sci 59:PL295-PL301.
42. Whittle BJ, Kauffman GL Jr, and Boughton-Smith NK (1984) Stimulation of gastric alkaline secretion by stable prostacyclin analogues in rat and dog. Eur J Pharmacol 100:277-283.
43. Xiao CY, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T, Takayama K, Takahata O, Karibe H, Taniguchi T, et al. (2004) Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation 109: 2462-2468.
44. Yasue N, Chan ET, Kaplowitz N, and Guth PH (1992) Effect of phorone and allopurinol on ischemia-reperfusion injury in gastrointestinal mucosa of the rat. Pharmacology 44:334-343.
45. Zimmerman BJ, Guillory DJ, Grisham MB, Gaginella TS, and Granger DN (1990) Role of leukotriene B4 in granulocyte infiltration into the postischemic feline intestine. Gastroenterology 99:1358-1363.